Dataset from A Randomized, Multicenter, International, Open-label Study of Infliximab Plus Methotrexate Versus Methotrexate (MTX) Alone for the Treatment of MTX naïve Subjects With Active Psoriatic Arthritis

This study is undertaken to compare the efficacy and onset of action of infliximab plus
methotrexate (IFX + MTX) versus methotrexate alone (MTX) in methotrexate naïve active
psoriatic arthritis patients.